4価ワクチンの世界市場レポート 2025年

4価ワクチン市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.3％で142億2,000万米ドルに成長します。予測期間の成長は、世界の健康イベント、競合のダイナミクス、教育キャンペーン、規制の変更、進化する疾患パターンに起因しています。予測期間の主な動向には、疾患の流行、規制環境、ヘルスケアインフラ、消費者の意識と教育、競合情勢などがあります。

慢性疾患および感染症の有病率の増加が、今後の4価ワクチン市場の成長を牽引すると予測されます。慢性疾患は遺伝や生活習慣に起因する長期的な疾患であり、感染症はウイルス、細菌、真菌、原虫などの感染因子によって引き起こされるあらゆる疾患です。4価ワクチンワクチンは、重篤な感染症による罹患率や死亡率を予防し、特定の感染症以外の疾患にも対処する上で重要な役割を果たしています。これらのワクチンは、感染因子が発がんに関与している場合、慢性（非感染性）疾患の予防にも利用されます。例えば、2024年9月、米国の非営利団体である疾病対策予防センターの報告によると、第37週は検体の0.5％がインフルエンザ陽性で、91.4％がA型インフルエンザ、8.6％がB型インフルエンザでした。2023年10月1日（第40週）から累計すると、検体の8.7％が陽性で、69.2％がA型インフルエンザ、30.8％がB型インフルエンザでした。したがって、慢性疾患や感染症の有病率の上昇が4価ワクチン市場の成長を牽引しています。

4価ワクチン市場の成長が期待される背景には、世界の予防接種率の拡大もあります。定義された期間内に特定のワクチンを接種した人口の割合を示す予防接種率は、ワクチン需要の増加を促進します。4種類の株を予防する4価ワクチンワクチンは、1回の接種で複数の病気の脅威に対処するため、定期接種プログラムに組み込まれることが多いです。世界保健機関（WHO）は、接種ゼロの子どもの数が改善し、2021年の1,810万人から2022年には1,430万人に減少すると報告しています。さらに、女児におけるヒトパピローマウイルス（HPV）ワクチンの世界の初回接種率は、2021年の16％から2022年には21％に上昇しました。このように、世界の予防接種率の上昇は、4価ワクチン市場を前進させると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界4価ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の4価ワクチン市場：成長率分析
• 世界の4価ワクチン市場の実績：規模と成長, 2019-2024
• 世界の4価ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界4価ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の4価ワクチン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮内注射
• 筋肉内注射
• 鼻スプレー
• 世界の4価ワクチン市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 活用形
• ライブ
• 不活性化
• 組み換え
• トキソイド
• その他のテクノロジー
• 世界の4価ワクチン市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん
• 肝炎
• 肺炎球菌感染症
• COVID-19
• インフルエンザ
• ヒトパピローマウイルス
• 髄膜炎菌感染症
• ポリオ
• ロタウイルス
• その他の病気
• 世界の4価ワクチン市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児科
• 成人用
• 世界の4価ワクチン市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と薬局
• 政府サプライヤー
• その他のチャネル（NGO）
• 世界の4価ワクチン市場皮内注射のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準皮内注射
• 針を使わない皮内投与
• 世界の4価ワクチン市場筋肉内注射の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準的な筋肉内注射
• アジュバント筋肉内注射
• 世界の4価ワクチン市場、鼻スプレーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生弱毒化鼻スプレー
• 不活化鼻スプレー

第7章 地域別・国別分析

• 世界の4価ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の4価ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 4価ワクチン市場：競合情勢
• 4価ワクチン市場：企業プロファイル
  • AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • Serum Institute of India Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • CSL Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bharat Biotech International Limited
• Hualan Biological Engineering Inc.
• Merck & Co. Inc.
• Johnson & Johnson Services Inc.
• Pfizer Inc.
• Bio Med Pvt. Ltd.
• Walvax Biotechnology Co. Ltd.
• Chongqing Zhifei Biological Products Co. Ltd.
• Emergent BioSolutions Inc.
• Biological E. Limited
• GSK Biologicals SA
• Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences
• Wuhan Institute of Biological Products Co. Ltd.
• Beijing Tian Tan Biological Products Co. Ltd.
• Shanghai Zhijiang Bio-pharm Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 4価ワクチン市場2029：新たな機会を提供する国
• 4価ワクチン市場2029：新たな機会を提供するセグメント
• 4価ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A quadrivalent vaccine stimulates the immune system to respond to distinct antigens, typically targeting four different viruses or bacteria. In the context of influenza, a quadrivalent vaccine is designed to provide protection against four specific flu viruses, including two type A and two type B viruses.

The primary types of quadrivalent vaccines include intradermal shots, intramuscular injections, and nasal sprays. An intradermal shot involves injecting the vaccine between the epidermis and hypodermis, the top and bottom layers of the skin, as defined by the Center for Disease Control (CDC). These vaccines are formulated using various technologies, including conjugated, live, inactivated, recombinant, toxoid, and others, aiming to immunize against a range of diseases such as cancer, hepatitis, pneumococcal disease, COVID-19, influenza, human papillomavirus, meningococcal disease, polio, rotavirus, and others affecting both pediatric and adult age groups. Distribution channels for these vaccines include hospitals, pharmacies, government suppliers, and other outlets.

The quadrivalent market research report is one of a series of new reports from The Business Research Company that provides quadrivalent market statistics, including quadrivalent industry global market size, regional shares, competitors with a quadrivalent market share, detailed quadrivalent market segments, market trends and opportunities, and any further data you may need to thrive in the quadrivalent industry. This quadrivalent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quadrivalent market size has grown strongly in recent years. It will grow from $8.87 billion in 2024 to $9.61 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to disease complexity, educational initiatives, past health events, healthcare growth, technological progress.

The quadrivalent market size is expected to see rapid growth in the next few years. It will grow to $14.22 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to global health events, competitive dynamics, educational campaigns, regulatory changes, evolving disease patterns. Major trends in the forecast period include disease prevalence, regulatory environment, healthcare infrastructure, consumer awareness and education, competitive landscape.

The increasing prevalence of chronic and infectious diseases is anticipated to drive the growth of the quadrivalent market in the future. A chronic disease is a long-term condition resulting from genetics and lifestyle, while an infectious disease is any illness caused by an infectious agent such as a virus, bacteria, fungus, or protozoan. Quadrivalent vaccines play a crucial role in preventing morbidity and mortality from serious infections, as well as addressing diseases beyond the specific infections they are designed to combat. These vaccines are also utilized to prevent chronic (non-communicable) diseases when infectious agents contribute to carcinogenesis. For instance, in September 2024, a report from the Centers for Disease Control and Prevention, a non-profit organization based in the U.S., indicated that in Week 37, 0.5% of specimens tested positive for influenza, with 91.4% being influenza A and 8.6% influenza B. Cumulatively, since October 1, 2023 (Week 40), 8.7% of specimens tested positive, with 69.2% being influenza A and 30.8% influenza B, reflecting a higher overall positivity rate and an increasing proportion of influenza B cases over time. Therefore, the rising prevalence of chronic and infectious diseases is driving the growth of the quadrivalent market.

The expected growth in the quadrivalent market is also fueled by the global expansion of immunization coverage. Immunization coverage, indicating the proportion of a population receiving specific vaccines within a defined period, drives increased demand for vaccines. Quadrivalent vaccines, protecting against four strains, are often integrated into routine vaccination programs to combat multiple disease threats in a single shot. The World Health Organization reported an improvement in the number of zero-dose children, decreasing from 18.1 million in 2021 to 14.3 million in 2022. Moreover, global coverage for the initial dose of the human papillomavirus (HPV) vaccine in girls increased from 16% in 2021 to 21% in 2022. Thus, the rising global immunization coverage is expected to propel the quadrivalent market forward.

A key trend gaining prominence in the quadrivalent market is product innovation. Major companies in the sector are actively developing innovative solutions to reinforce their market positions. AstraZeneca, a UK-based pharmaceutical company, launched FluMist quadrivalent (Influenza Vaccination Live, Intranasal) in September 2022. This FDA-approved nasal-spray flu vaccine for individuals aged 2 to 49 is administered through a needle-free nasal spray. It is available in trivalent or quadrivalent formulations, providing a live attenuated influenza vaccine (LAIV) covered by most health insurance plans and the vaccines for children program.

Major companies operating in the quadrivalent market are prioritizing safer and innovative vaccine delivery technologies, such as nanoparticle technology, to boost their revenues. This nanoparticle technology mimics the virus's outer structure using virus-like particles (VLPs) without containing any live genetic material, which enhances both safety and immune response. For example, in March 2024, Cadila Pharmaceuticals, a pharmaceutical company based in India, launched its advanced Quadrivalent Influenza Vaccine, designed to provide protection against four distinct strains of the influenza virus, including two A strains (H1N1 and H3N2) and two B strains. This quadrivalent formulation improves the vaccine's efficacy by targeting a broader range of circulating influenza viruses, making it particularly effective during flu seasons. The aQIV aims to stimulate a strong immune response, thereby reducing the incidence of influenza-related morbidity and mortality. Its development highlights ongoing efforts to enhance public health outcomes in response to evolving viral strains.

In February 2023, China-based biotechnology company Clover Biopharmaceuticals Ltd. entered into a partnership with Adimmune Corporation, a Taiwan-based biopharmaceutical company. This collaboration leverages Adimmune's manufacturing and distribution expertise in providing essential vaccines to Asian populations. Clover aims to strengthen its position as a premier respiratory vaccine franchise and enhance synergies with ongoing COVID-19 vaccine commercialization. As part of this collaboration, Clover will distribute Adimmune's AdimFlu-S (QIS), the only imported quadrivalent influenza vaccination authorized in mainland China, utilizing its established commercial infrastructure.

Major companies operating in the quadrivalent market include AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

North America was the largest region in the quadrivalent market in 2024. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the quadrivalent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quadrivalent market consists of sales of afluria quadrivalent, fluarix quadrivalent, flublok quadrivalent, fluzone quadrivalent (influenza virus vaccine), flulaval quadrivalent, flucelvax quadrivalent, menactra and menveo. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quadrivalent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quadrivalent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quadrivalent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The quadrivalent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Intradermal Shot; Intramuscular Injection; Nasal Spray
• 2) By Technology: Conjugated; Live; Inactivated; Recombinant; Toxoid; Other Technologies
• 3) By Disease: Cancer; Hepatitis; Pneumococcal Disease; COVID-19; Influenza; Human Papilloma Virus; Meningococcal Disease; Polio; Rotavirus; Other Diseases
• 4) By Age Group: Pediatric; Adult
• 5) By Distribution Channel: Hospital And Pharmacy; Government Suppliers; Other Channels (NGOs)
• Subsegments:
• 1) By Intradermal Shot: Standard Intradermal Injection; Needle-Free Intradermal Delivery
• 2) By Intramuscular Injection: Standard Intramuscular Injection; Adjuvanted Intramuscular Injection
• 3) By Nasal Spray: Live Attenuated Nasal Spray; Inactivated Nasal Spray
• Companies Mentioned: AstraZeneca Plc; Serum Institute of India Private Limited; Sanofi S.A.; GlaxoSmithKline Plc; CSL Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Quadrivalent Market Characteristics

3. Quadrivalent Market Trends And Strategies

4. Quadrivalent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Quadrivalent Growth Analysis And Strategic Analysis Framework

• 5.1. Global Quadrivalent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Quadrivalent Market Growth Rate Analysis
• 5.4. Global Quadrivalent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Quadrivalent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Quadrivalent Total Addressable Market (TAM)

6. Quadrivalent Market Segmentation

• 6.1. Global Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intradermal Shot
• Intramuscular Injection
• Nasal Spray
• 6.2. Global Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conjugated
• Live
• Inactivated
• Recombinant
• Toxoid
• Other Technologies
• 6.3. Global Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Hepatitis
• Pneumococcal Disease
• COVID-19
• Influenza
• Human Papilloma Virus
• Meningococcal Disease
• Polio
• Rotavirus
• Other Diseases
• 6.4. Global Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric
• Adult
• 6.5. Global Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital And Pharmacy
• Government Suppliers
• Other Channels (NGOs)
• 6.6. Global Quadrivalent Market, Sub-Segmentation Of Intradermal Shot, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Intradermal Injection
• Needle-Free Intradermal Delivery
• 6.7. Global Quadrivalent Market, Sub-Segmentation Of Intramuscular Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Intramuscular Injection
• Adjuvanted Intramuscular Injection
• 6.8. Global Quadrivalent Market, Sub-Segmentation Of Nasal Spray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Nasal Spray
• Inactivated Nasal Spray

7. Quadrivalent Market Regional And Country Analysis

• 7.1. Global Quadrivalent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Quadrivalent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Quadrivalent Market

• 8.1. Asia-Pacific Quadrivalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Quadrivalent Market

• 9.1. China Quadrivalent Market Overview
• 9.2. China Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Quadrivalent Market

• 10.1. India Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Quadrivalent Market

• 11.1. Japan Quadrivalent Market Overview
• 11.2. Japan Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Quadrivalent Market

• 12.1. Australia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Quadrivalent Market

• 13.1. Indonesia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Quadrivalent Market

• 14.1. South Korea Quadrivalent Market Overview
• 14.2. South Korea Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Quadrivalent Market

• 15.1. Western Europe Quadrivalent Market Overview
• 15.2. Western Europe Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Quadrivalent Market

• 16.1. UK Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Quadrivalent Market

• 17.1. Germany Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Quadrivalent Market

• 18.1. France Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Quadrivalent Market

• 19.1. Italy Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Quadrivalent Market

• 20.1. Spain Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Quadrivalent Market

• 21.1. Eastern Europe Quadrivalent Market Overview
• 21.2. Eastern Europe Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Quadrivalent Market

• 22.1. Russia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Quadrivalent Market

• 23.1. North America Quadrivalent Market Overview
• 23.2. North America Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Quadrivalent Market

• 24.1. USA Quadrivalent Market Overview
• 24.2. USA Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Quadrivalent Market

• 25.1. Canada Quadrivalent Market Overview
• 25.2. Canada Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Quadrivalent Market

• 26.1. South America Quadrivalent Market Overview
• 26.2. South America Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Quadrivalent Market

• 27.1. Brazil Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Quadrivalent Market

• 28.1. Middle East Quadrivalent Market Overview
• 28.2. Middle East Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Quadrivalent Market

• 29.1. Africa Quadrivalent Market Overview
• 29.2. Africa Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Quadrivalent Market Competitive Landscape And Company Profiles

• 30.1. Quadrivalent Market Competitive Landscape
• 30.2. Quadrivalent Market Company Profiles
  • 30.2.1. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Serum Institute of India Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

31. Quadrivalent Market Other Major And Innovative Companies

• 31.1. Bharat Biotech International Limited
• 31.2. Hualan Biological Engineering Inc.
• 31.3. Merck & Co. Inc.
• 31.4. Johnson & Johnson Services Inc.
• 31.5. Pfizer Inc.
• 31.6. Bio Med Pvt. Ltd.
• 31.7. Walvax Biotechnology Co. Ltd.
• 31.8. Chongqing Zhifei Biological Products Co. Ltd.
• 31.9. Emergent BioSolutions Inc.
• 31.10. Biological E. Limited
• 31.11. GSK Biologicals SA
• 31.12. Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences
• 31.13. Wuhan Institute of Biological Products Co. Ltd.
• 31.14. Beijing Tian Tan Biological Products Co. Ltd.
• 31.15. Shanghai Zhijiang Bio-pharm Co. Ltd.

32. Global Quadrivalent Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Quadrivalent Market

34. Recent Developments In The Quadrivalent Market

35. Quadrivalent Market High Potential Countries, Segments and Strategies

• 35.1 Quadrivalent Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Quadrivalent Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Quadrivalent Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer